title: [A follow-up study of 420 cases of cerebral cysticercosis].
abstract: 420 patients with cerebral cysticercosis, including 97 with intracranial hypertension, were treated by praziquantel 30-50 mg/kg a day, 7-10 days a course. Of the 420 patients, 252, 144 and 24 were treated for one, two and three courses respectively. 1-6 years' follow-up study showed 366 were completely recovered (87.14%) and 399 had effect (95.00%); 12 had inefficacy and 9 died (5.00%). It is believed that the serious acute allergic reactions might be eliminated by "desensitization" of a small dose of praziquantel; intracranial hypertension can be lowered by intrathecal injection of dexamethasone; and ventricular and intra-ocular cysticercosis can also be treated by praziquantel.
authors: 2nd Affiliated Hospital of Hebei Medical College, Hebei.
authors: S
authors: S
authors: Zhu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001927:Brain Diseases / Q000188:drug therapy / Q000469:parasitology*; D002648:Child; D002675:Child, Preschool; D003551:Cysticercosis / Q000188:drug therapy*; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011223:Praziquantel / Q000627:therapeutic use*; D011559:Pseudotumor Cerebri / Q000188:drug therapy
chemical_list: D011223:Praziquantel; D003907:Dexamethasone